After Wegovy's Approval to Treat Heart Disease, Novo Nordisk Continues to Make Moves
Novo Nordisk is off to a red-hot start in 2024, and its latest deal could represent huge potential.... Read more
Bron: ![](/logo/6585.png)
Fool.com: The Motley Fool
Tags:
Geplaatst: 04 Apr 2024 - 13:30